Valuation: Spectral AI, Inc.

Market Cap 53.43M 47.47M 44.31M 40.38M 76.16M 5.14B 76.87M 536M 208M 2.63B 201M 196M 8.43B P/E 2026 *
-3.56x
P/E 2027 * -5.35x
Enterprise Value 53.43M 47.47M 44.31M 40.38M 76.16M 5.14B 76.87M 536M 208M 2.63B 201M 196M 8.43B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 1.65x
Free-Float
86.68%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 59 09/02/2026
Chief Executive Officer 57 11/09/2023
Director of Finance/CFO 47 04/05/2026
Director TitleAgeSince
Chairman 65 11/09/2023
Director/Board Member 68 01/06/2021
Director/Board Member 52 11/09/2023
Change 5-day change 1-year change 3-year change Capi.($)
+10.48%+19.83% - - 53.43M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average +0.63%-2.50%-2.15%+22.20% 91.4B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%

Financials

2026 *2027 *
Net sales 18.53M 16.46M 15.37M 14M 26.41M 1.78B 26.66M 186M 72.05M 911M 69.57M 68.06M 2.92B 32.42M 28.81M 26.89M 24.51M 46.22M 3.12B 46.65M 325M 126M 1.59B 122M 119M 5.11B
Net income -15.21M -13.51M -12.61M -11.49M -21.68M -1.46B -21.88M -153M -59.13M -747M -57.09M -55.85M -2.4B -11.15M -9.91M -9.25M -8.43M -15.89M -1.07B -16.04M -112M -43.36M -548M -41.86M -40.95M -1.76B
Net Debt - -
Logo Spectral AI, Inc.
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Employees
65
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-